NAD+ at a glance
| Detail | What the sources say |
|---|---|
| What it is | Nicotinamide adenine dinucleotide, a coenzyme in all cells |
| Human evidence | Small pilot and retrospective studies of NAD+ given directly |
| Reported reactions | Stomach and gut symptoms, a faster heart rate and chest pressure during infusions (retrospective study) |
| FDA action | Warning letter to a compounding facility, January 2026; the FDA states NAD+ is not on the 503B bulk substances list |
| Not the same as | Precursors such as NR and NMN, whose results are not NAD+ results |
From the sources to the app
| What the sources say | What PepLabo does with it |
|---|---|
| NAD+ infusions are offered in some clinics [2]. | Choose a vial or Infusion container as the form; each session is saved with the date and time. |
| Reactions during infusions have been reported [2]. | Check-ins record symptoms with a severity and can be linked to a dose from the previous 72 hours; an export or a PDF report (Pro) helps you show them to a clinician. |
| The FDA’s warning concerned one lot of a compounded product [3]. | Lot and expiry fields keep each vial distinct, and a label scan fills in the text from the vial. |
What PepLabo does and does not do
| PepLabo does | PepLabo does not |
|---|---|
| Record each dose with the date, time and amount you enter, and the site for injections | Suggest a dose, a schedule change or a medicine |
| Remind you 15 minutes before, at the dose time, and 30 minutes after a missed dose | Tell you what to do after a missed dose; the leaflet and your prescriber do |
| Put check-ins, weight and doses on one timeline | Interpret symptoms or judge progress |
| Keep your records on your phone, with no account needed to track | Use analytics, advertising or tracking SDKs, or write to Apple Health |
| Create a PDF of your dose log for your clinician (Pro) | Replace your clinician or pharmacist |
